Skip to main content

Thomas Briston, PhD/MPharm

Scientist and Project Leader at Eisai

Location: Hatfield United Kingdom

Thomas Briston is a scientist and project leader at Eisai. He received his Master of Pharmacy degree from the School of Pharmacy, University of London and completed his pre-registration training at the University Hospital of South Manchester. Dr. Briston obtained his PhD from UCL, studying the relationship between the oxygen-sensing pathway and E3-ubiquitin ligase VHL on mitochondrial form and function. His post-doctoral studies have continued to focus on mitochondrial biology, specifically that of the mitochondrial permeability transition pore and its potential as a drug target in Parkinson’s disease. Dr. Briston joined Eisai in 2015 and has since worked across multiple Parkinson’s disease drug discovery projects. He now leads a pre-clinical program in collaboration with UCL.

Associated Grants

  • Identification of Novel Compounds that Improve Mitochondrial Quality Control


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.